Assessing antiviral treatment efficacy and risk factors for severe COVID-19 in kidney transplant recipients during the Omicron subvariant-dominant period: a retrospective study.
Sakaguchi T, Mitsuke A, Osako Y, Yamada Y, Takeyama H, Ogawa R, Takahashi K, Hirohata Y, Yamamoto S, Arima J, Fukumoto W, Sugita S, Inoguchi S, Matsushita R, Yoshino H, Tatarano S, Enokida H.
Sakaguchi T, et al. Among authors: takeyama h.
BMC Nephrol. 2024 Apr 8;25(1):124. doi: 10.1186/s12882-024-03561-7.
BMC Nephrol. 2024.
PMID: 38589827
Free PMC article.